• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

clinical trial data

Eli Lillys Lilly Seaport Innovation Center in Boston
Pharma

Lilly's Ebglyss scores eczema trial win in children

With positive results from a phase 3 trial, Eli Lilly is set up to make Ebglyss available to a younger group of eczema patients.
Kevin Dunleavy Mar 16, 2026 10:50am
dart board miss failure

Neurocrine's Ingrezza misses in cerebral palsy trial

Dec 23, 2025 10:20am
Gilead

Gilead's single-tablet HIV combo passes 2nd late-stage test

Dec 16, 2025 9:15am
Pfizer

Pfizer details Tukysa's 1st-line data in HER2 breast cancer

Dec 10, 2025 8:15am
Bristol Myers Squibb

With site 'irregularities,' BMS delays key Cobenfy readout

Dec 3, 2025 10:14am
Close up shot of the target from a dart game

Akeso details ivonescimab's 1st overall survival win

Nov 7, 2025 11:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings